300436 Stock Overview
Engages in the research and development, manufacture, and sale of pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Fujian Cosunter Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥17.87 |
| 52 Week High | CN¥31.84 |
| 52 Week Low | CN¥14.16 |
| Beta | 0.81 |
| 11 Month Change | 13.39% |
| 3 Month Change | -5.35% |
| 1 Year Change | -33.52% |
| 33 Year Change | -48.31% |
| 5 Year Change | -49.72% |
| Change since IPO | 15.59% |
Recent News & Updates
Shareholder Returns
| 300436 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 18.1% | 6.4% | 0.4% |
| 1Y | -33.5% | -10.6% | -21.0% |
Return vs Industry: 300436 underperformed the CN Pharmaceuticals industry which returned -10.6% over the past year.
Return vs Market: 300436 underperformed the CN Market which returned -21% over the past year.
Price Volatility
| 300436 volatility | |
|---|---|
| 300436 Average Weekly Movement | 6.7% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 300436 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300436's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 908 | Guoping Li | www.cosunter.com |
Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers medicines for anti-HBV, liver diseases, digestive, respiratory, cardiovascular, men’s health, and other fields. The company primarily produces crude drug and solid preparation in the forms of tablet, capsule, granule, medicinal tea, etc. Fujian Cosunter Pharmaceutical Co., Ltd.
Fujian Cosunter Pharmaceutical Co., Ltd. Fundamentals Summary
| 300436 fundamental statistics | |
|---|---|
| Market cap | CN¥2.78b |
| Earnings (TTM) | -CN¥299.92m |
| Revenue (TTM) | CN¥454.53m |
6.3x
P/S Ratio-9.5x
P/E RatioIs 300436 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300436 income statement (TTM) | |
|---|---|
| Revenue | CN¥454.53m |
| Cost of Revenue | CN¥197.79m |
| Gross Profit | CN¥256.75m |
| Other Expenses | CN¥556.67m |
| Earnings | -CN¥299.92m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 28, 2024
| Earnings per share (EPS) | -1.88 |
| Gross Margin | 56.49% |
| Net Profit Margin | -65.99% |
| Debt/Equity Ratio | 87.6% |
How did 300436 perform over the long term?
See historical performance and comparison